©The Author(s) 2025.
World J Clin Oncol. Dec 24, 2025; 16(12): 112161
Published online Dec 24, 2025. doi: 10.5306/wjco.v16.i12.112161
Published online Dec 24, 2025. doi: 10.5306/wjco.v16.i12.112161
Figure 4 Chaperonin-containing TCP1 subunit 3 mRNA has a strong discriminatory performance in laryngeal squamous cell carcinoma.
A: The positive diagnostic likelihood ratio is 9.48, and the negative diagnostic likelihood ratio is 0.18; B: The overall sensitivity of the test is 0.84, and the specificity is 0.91.
- Citation: Mo BY, Wen JY, Chen GQ, Ling JW, He H, Qin ZL, Tian FY, Li Q, Li B, Li JD, He RQ, Qin DY, Li ZY, Chen G, Mo CH, Chen C, Yin SH, Yang L. Expression patterns and clinical implications of chaperonin subunit 3 mRNA and protein in laryngeal squamous cell carcinoma. World J Clin Oncol 2025; 16(12): 112161
- URL: https://www.wjgnet.com/2218-4333/full/v16/i12/112161.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i12.112161